OSSIOfiber®
-
Extremities
OSSIO introduces OSSIOfiber® Threaded Trimmable Fixation Nail to improve orthopedic surgery and simplify inventory management
Use cases for latest addition to company’s expanding product portfolio include hand and wrist, foot and ankle, sports medicine, and…
Read More » -
Extremities
OSSIO expands portfolio of highly differentiated bio-integrative fixation implants with small compression staples to enhance bunion repair patients’ satisfaction
OSSIOfiber Small Compression Staple & Inserter Revolutionary material science innovation, OSSIOfiber® continues to evolve standard of care in orthopedic surgery. WOBURN,…
Read More » -
Regulatory
OSSIO’s Groundbreaking Option for Fixing Bone Fractures In Children Receives FDA Clearance
OSSIOfiber Intelligent Bone Regeneration Technology Supported by Clinical Data Presented at IPOS 2023, Pediatric Indication for OSSIOfiber® Bio-Integrative Orthopedic Fixation Technology…
Read More » -
Extremities
OSSIO Launches World’s First and Only Non-Permanent Compression Staple
OSSIOfiber® Compression Staple Answers Surgeon, Patient Demand in Fastest Growing Product Category in Extremities February 7, 2023 WOBURN, Mass.–(BUSINESS WIRE)– OSSIO, Inc.,…
Read More » -
Extremities
OSSIO Announces U.S. Launch and First Commercial Use of OSSIOfiber® Suture Anchors, Expanding Patient Access to Growing Portfolio of Bio-Integrative Orthopedic Fixation Technology
Indications for Use Include Surgery on Foot/Ankle, Shoulder, Knee, Hand/Wrist and Elbow Advantages Over Traditional Anchors Include Self-Tapping Insertion Strength, Superior Pull-Out…
Read More » -
Regulatory
OSSIO Achieves Third FDA Clearance in 4 Months for OSSIOfiber® Implants; Prepares to Expand Patient Access to Bio-Integrative Orthopedic Fixation Technology Portfolio in Q2/Q3
New Suture Anchors, Industry’s First U.S.-Cleared Non-Permanent Compression Staples and Additional Compression Screws to Join Previously Launched Products That Leave…
Read More » -
Extremities
OSSIO Receives Vizient Contract for Bio-Integrative Orthopedic Fixation Technology
Three-year contract makes company’s full OSSIOfiber® implant portfolio available to thousands of health care providers in largest U.S. GPO, greatly expanding…
Read More » -
Extremities
OSSIO Announces U.S. Launch and First Commercial Use of the Bio-Integrative OSSIOfiber®Compression Screw Portfolio
Company Secures $20 Million in Financing to Accelerate Product Development & Advance Commercialization WOBURN, Mass. – OSSIO, Inc., an orthopedic…
Read More » -
Extremities
OSSIO Awarded FDA 510(k) Clearance for OSSIOfiber® Compression Screw Portfolio
Company Successfully Surpasses 1,000th Implantation Milestone for its Strong and Bio-integrative OSSIOfiber® Technology WOBURN, Mass., October 19, 2020– OSSIO, Inc.,…
Read More » -
Extremities
OSSIO Announces U.S. Launch and First Commercial Use of the OSSIOfiber® Trimmable Fixation Nail System for Broad Utilization in Foot/Ankle and Hand/Wrist Procedures
July 22, 2020 WOBURN, Mass.–(BUSINESS WIRE)–OSSIO, Inc., an orthopedic fixation company, today announced the U.S. launch and first commercial use…
Read More » -
Extremities
OSSIO Receives FDA 510(k) Clearance for OSSIOfiber® Hammertoe Fixation System
March 12, 2020 WOBURN, Mass.–(BUSINESS WIRE)–OSSIO, Inc., an orthopedic fixation company, today announced that its OSSIOfiber® Hammertoe Fixation System has…
Read More »